Literature DB >> 32531846

Genotype-phenotype associations in a large PRPH2-related retinopathy cohort.

Melissa J Reeves1, Kerry E Goetz2, Bin Guan1, Ehsan Ullah1, Delphine Blain1, Wadih M Zein1, Santa J Tumminia2, Robert B Hufnagel1.   

Abstract

Molecular variant interpretation lacks disease gene-specific cohorts for determining variant enrichment in disease versus healthy populations. To address the molecular etiology of retinal degeneration, specifically the PRPH2-related retinopathies, we reviewed genotype and phenotype information obtained from 187 eyeGENE® participants from 161 families. Clinical details were provided by referring clinicians participating in the eyeGENE® Network. The cohort was sequenced for variants in PRPH2. Variant complementary DNA clusters and cohort frequency were compared to variants in public databases to help us to determine pathogenicity by current American College of Medical Genetics and Genomics/Association for Molecular Pathology interpretation criteria. The most frequent variant was c.828+3A>T, which affected 28 families (17.4%), and 25 of 79 (31.64%) variants were novel. The majority of missense variants clustered in the D2 intracellular loop of the peripherin-2 protein, constituting a hotspot. Disease enrichment was noted for 23 (29.1%) of the variants. Hotspot and disease-enrichment evidence modified variant classification for 16.5% of variants. The missense allele p.Arg172Trp was associated with a younger age of onset. To the best of our knowledge, this is the largest patient cohort review of PRPH2-related retinopathy. Large disease gene-specific cohorts permit gene modeling for hotspot and disease-enrichment analysis, providing novel variant classification evidence, including for novel missense variants. Published 2020. This article is a U.S. Goverment work and is in the public domain in the USA.

Entities:  

Keywords:  PRPH2; clinical variant interpretation; eyeGENE; genotype; phenotype; retinopathy

Mesh:

Substances:

Year:  2020        PMID: 32531846      PMCID: PMC7484419          DOI: 10.1002/humu.24065

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.700


  45 in total

1.  Mutations in known genes account for 58% of autosomal dominant retinitis pigmentosa (adRP).

Authors:  Stephen P Daiger; Lori S Sullivan; Anisa I Gire; David G Birch; John R Heckenlively; Sara J Bowne
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

2.  Protter: interactive protein feature visualization and integration with experimental proteomic data.

Authors:  Ulrich Omasits; Christian H Ahrens; Sebastian Müller; Bernd Wollscheid
Journal:  Bioinformatics       Date:  2013-10-24       Impact factor: 6.937

Review 3.  Tetraspanins at a glance.

Authors:  Stéphanie Charrin; Stéphanie Jouannet; Claude Boucheix; Eric Rubinstein
Journal:  J Cell Sci       Date:  2014-08-15       Impact factor: 5.285

4.  Prevalence of mutations causing retinitis pigmentosa and other inherited retinopathies.

Authors:  M M Sohocki; S P Daiger; S J Bowne; J A Rodriquez; H Northrup; J R Heckenlively; D G Birch; H Mintz-Hittner; R S Ruiz; R A Lewis; D A Saperstein; L S Sullivan
Journal:  Hum Mutat       Date:  2001       Impact factor: 4.878

5.  ABCA4 and ROM1: implications for modification of the PRPH2-associated macular dystrophy phenotype.

Authors:  Charlotte M Poloschek; Michael Bach; Wolf A Lagrèze; Esther Glaus; Johannes R Lemke; Wolfgang Berger; John Neidhardt
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-24       Impact factor: 4.799

6.  Quantitative Fundus Autofluorescence and Optical Coherence Tomography in PRPH2/RDS- and ABCA4-Associated Disease Exhibiting Phenotypic Overlap.

Authors:  Tobias Duncker; Stephen H Tsang; Russell L Woods; Winston Lee; Jana Zernant; Rando Allikmets; François C Delori; Janet R Sparrow
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

Review 7.  Retinal blinding disorders and gene therapy--molecular and clinical aspects.

Authors:  Birgit Lorenz; Markus Preising; Knut Stieger
Journal:  Curr Gene Ther       Date:  2010-10       Impact factor: 4.391

8.  Biochemical analysis of phenotypic diversity associated with mutations in codon 244 of the retinal degeneration slow gene.

Authors:  Shannon M Conley; Heidi M Stricker; Muna I Naash
Journal:  Biochemistry       Date:  2010-02-09       Impact factor: 3.162

Review 9.  Smelling the roses and seeing the light: gene therapy for ciliopathies.

Authors:  Jeremy C McIntyre; Corey L Williams; Jeffrey R Martens
Journal:  Trends Biotechnol       Date:  2013-04-17       Impact factor: 19.536

10.  eyeGENE®: a vision community resource facilitating patient care and paving the path for research through molecular diagnostic testing.

Authors:  D Blain; K E Goetz; R Ayyagari; S J Tumminia
Journal:  Clin Genet       Date:  2013-06-05       Impact factor: 4.438

View more
  9 in total

1.  Genetic and Phenotypic Landscape of PRPH2-Associated Retinal Dystrophy in Japan.

Authors:  Akio Oishi; Kaoru Fujinami; Go Mawatari; Nobuhisa Naoi; Yasuhiro Ikeda; Shinji Ueno; Kazuki Kuniyoshi; Takaaki Hayashi; Hiroyuki Kondo; Atsushi Mizota; Kei Shinoda; Sentaro Kusuhara; Makoto Nakamura; Takeshi Iwata; Akitaka Tsujikawa; Kazushige Tsunoda
Journal:  Genes (Basel)       Date:  2021-11-18       Impact factor: 4.096

2.  Clinical-genetic findings in a group of subjects with macular dystrophies due to mutations in rare inherited retinopathy genes.

Authors:  Juan C Zenteno; Rocio Arce-Gonzalez; Rodrigo Matsui; Antonio Lopez-Bolaños; Luis Montes; Alan Martinez-Aguilar; Oscar F Chacon-Camacho
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-08-10       Impact factor: 3.535

Review 3.  The Neuroprotective Role of Retbindin, a Metabolic Regulator in the Neural Retina.

Authors:  Xue Zhao; Lars Tebbe; Muna I Naash; Muayyad R Al-Ubaidi
Journal:  Front Pharmacol       Date:  2022-07-06       Impact factor: 5.988

4.  PRPH2 mutation update: In silico assessment of 245 reported and 7 novel variants in patients with retinal disease.

Authors:  Manon H C A Peeters; Mubeen Khan; Anoek A M B Rooijakkers; Timo Mulders; Lonneke Haer-Wigman; Camiel J F Boon; Caroline C W Klaver; L Ingeborgh van den Born; Carel B Hoyng; Frans P M Cremers; Anneke I den Hollander; Claire-Marie Dhaenens; Rob W J Collin
Journal:  Hum Mutat       Date:  2021-09-20       Impact factor: 4.700

5.  Predominant Founder Effect among Recurrent Pathogenic Variants for an X-Linked Disorder.

Authors:  Chelsea Bender; Elizabeth Geena Woo; Bin Guan; Ehsan Ullah; Eric Feng; Amy Turriff; Santa J Tumminia; Paul A Sieving; Catherine A Cukras; Robert B Hufnagel
Journal:  Genes (Basel)       Date:  2022-04-12       Impact factor: 4.141

6.  Delineating the Clinical Phenotype of Patients With the c.629C>G, p.Pro210Arg Mutation in Peripherin-2.

Authors:  Shannon M Conley; Cynthia K McClard; Maggie L Mwoyosvi; Niyaf Alkadhem; Bojana Radojevic; Martin Klein; David Birch; Ashley Ellis; Sonny W Icks; Tejesh Guddanti; Lea D Bennett
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-07-08       Impact factor: 4.925

Review 7.  Genetic dissection of non-syndromic retinitis pigmentosa.

Authors:  Aarti Bhardwaj; Anshu Yadav; Manoj Yadav; Mukesh Tanwar
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

8.  Photoreceptor and Retinal Pigment Epithelium Relationships in Eyes With Vitelliform Macular Dystrophy Revealed by Multimodal Adaptive Optics Imaging.

Authors:  Tao Liu; Nancy Aguilera; Andrew J Bower; Joanne Li; Ehsan Ullah; Alfredo Dubra; Catherine Cukras; Brian P Brooks; Brett G Jeffrey; Robert B Hufnagel; Laryssa A Huryn; Wadih M Zein; Johnny Tam
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-07-08       Impact factor: 4.925

9.  Multimodal Study of PRPH2 Gene-Related Retinal Phenotypes.

Authors:  Giulio Antonelli; Mariacristina Parravano; Lucilla Barbano; Eliana Costanzo; Matteo Bertelli; Maria Chiara Medori; Vincenzo Parisi; Lucia Ziccardi
Journal:  Diagnostics (Basel)       Date:  2022-07-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.